Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | STAT3 | P40763 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PSMD10 | O75832 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | MMP9 | P14780 | 2/20 | 0.38 |
| ▸ | MMP8 | P22894 | 2/20 | 0.38 |
| ▸ | MMP13 | P45452 | 2/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30244568 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL16898428 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL15416739 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL483840 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL1742594 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL916053 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL23417950 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL7519771 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL16899885 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 | |
| SCHEMBL564403 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CA1CA12CA9STAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260007786-A1 | COMPOUNDS FOR COATING OF NANOSTRUCTURES | SPAGO NANOMEDICAL AB (SE) | 2026-01-08 | — | — | US | disclosed |
| EP-4242250-A1 | COMPOUNDS FOR COATING OF NANOSTRUCTURES | Spago Nanomedical AB (SE) | 2023-09-13 | — | — | EP | disclosed |
| WO-2023059581-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASE | HALDA THERAPEUTICS OPCO, INC. (US) | 2023-04-13 | — | — | WO | disclosed |
| WO-2023059583-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASE | HALDA THERAPEUTICS OPCO, INC. (US) | 2023-04-13 | — | — | WO | disclosed |
| WO-2022251588-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | HALDA THERAPEUTICS OPCO, INC. (US) | 2022-12-01 | — | — | WO | disclosed |
| JP-5364532-B2 | — | — | 2013-12-11 | — | — | JP | disclosed |
| US-4165334-A | Detergent compounds and compositions | THE PROCTER & GAMBLE COMPANY (US) | 1979-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007786-A1 | COMPOUNDS FOR COATING OF NANOSTRUCTURES | SCO2, PYM1, SSB | ALDH1A1 4535/4885CA1 228/4885CA12 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.